Zheng Quan Ri Bao Wang·2025-09-26 10:12Core Viewpoint - The company, Yingkang Life, emphasizes its commitment to clinical value and long-term strategy in the fields of brain-computer interfaces and rehabilitation robotics, focusing on technological maturity and business synergy in its clinical explorations and collaborations [1] Group 1: Strategic Focus - The company is strategically focused on the entire industry chain of tumor pre-diagnosis and treatment, consistently communicating this strategy through regular reports, announcements, and investor engagement activities [1] - The management plans to leverage resources from the Haier ecosystem to steadily enhance core capabilities and actively seek frontier collaboration opportunities that align with its strategy [1] Group 2: Operational Approach - The company prioritizes the maturity of technology and commercial viability in its innovation efforts, reflecting the high technical barriers and stringent regulatory requirements of the medical industry [1] - The management will continue to optimize team structure and attract professional talent to drive high-quality development [1] Group 3: Market Outlook - The company expresses strong confidence in the long-term prospects of the health industry and aims to reward investors' trust through solid operational performance [1]